John Amerena

6.8k total citations · 1 hit paper
95 papers, 2.2k citations indexed

About

John Amerena is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John Amerena has authored 95 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John Amerena's work include Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Health and Mental Health (15 papers) and Cardiac Imaging and Diagnostics (14 papers). John Amerena is often cited by papers focused on Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Health and Mental Health (15 papers) and Cardiac Imaging and Diagnostics (14 papers). John Amerena collaborates with scholars based in Australia, United States and United Kingdom. John Amerena's co-authors include Stevo Julius, Lars Wallentin, Renato D. Lópes, John H. Alexander, Michael G. Hanna, Laine Thomas, Stefan H. Hohnloser, Mátyás Keltai, David Brieger and Christopher B. Granger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

John Amerena

89 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

2012 422 citations Stefan H. Hohnloser, Laine Thomas et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Amerena Australia	24	1.7k	362	310	239	191	95	2.2k
Thao Huynh Canada	26	1.7k 1.0×	600 1.7×	181 0.6×	134 0.6×	219 1.1×	120	2.5k
Mary Tan Canada	25	1.7k 1.0×	676 1.9×	249 0.8×	282 1.2×	129 0.7×	93	2.5k
Peter Weeke Denmark	31	1.7k 1.0×	463 1.3×	247 0.8×	335 1.4×	324 1.7×	96	3.9k
Jeffrey Schein United States	24	705 0.4×	335 0.9×	285 0.9×	151 0.6×	251 1.3×	58	1.9k
Kensey Gosch United States	28	1.4k 0.9×	768 2.1×	142 0.5×	135 0.6×	149 0.8×	127	2.2k
Eric C. Stecker United States	21	1.8k 1.1×	389 1.1×	208 0.7×	41 0.2×	139 0.7×	68	2.6k
Barbara S. Wiggins United States	15	761 0.5×	405 1.1×	384 1.2×	87 0.4×	148 0.8×	40	1.8k
H. Emerson Thomas United States	14	1.8k 1.1×	413 1.1×	213 0.7×	192 0.8×	369 1.9×	24	2.4k
Maria Dorobanţu Romania	27	1.8k 1.1×	521 1.4×	73 0.2×	233 1.0×	215 1.1×	151	2.5k
Taryn F. Moy United States	26	832 0.5×	317 0.9×	131 0.4×	279 1.2×	137 0.7×	47	2.2k

Countries citing papers authored by John Amerena

Since Specialization

Citations

This map shows the geographic impact of John Amerena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Amerena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Amerena more than expected).

Fields of papers citing papers by John Amerena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Amerena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Amerena. The network helps show where John Amerena may publish in the future.

Co-authorship network of co-authors of John Amerena

This figure shows the co-authorship network connecting the top 25 collaborators of John Amerena. A scholar is included among the top collaborators of John Amerena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Amerena. John Amerena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sindone, Andrew, Walter P. Abhayaratna, John Amerena, et al.. (2025). Heart Failure With Preserved Ejection Fraction in Patients With Obesity: A Growing Cardiometabolic Concern. Heart Lung and Circulation. 34(10). 1033–1040.

Hopper, Ingrid, Thomas H. Marwick, Rory Wolfe, et al.. (2025). STAREE-HEART: A randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants. American Heart Journal. 290. 140–152.

McMahon, Laura, Amerigo Giudice, Elias Wagner, et al.. (2024). Clozapine rechallenge following myocarditis: a systematic review of rechallenge cases. CNS Spectrums. 29(6). 585–592. 3 indexed citations

Grande, Michael Le, Barbara Murphy, Michelle Rogerson, et al.. (2023). Development of a short form of the Cardiac Distress Inventory. BMC Cardiovascular Disorders. 23(1). 408–408. 8 indexed citations

Segan, Louise, David Chieng, Hariharan Sugumar, et al.. (2023). The impact of age on ablation outcomes in AF‐mediated cardiomyopathy. Journal of Cardiovascular Electrophysiology. 34(10). 2065–2075.

Sindone, Andrew, Carmine G. De Pasquale, John Amerena, et al.. (2022). Consensus statement on the current pharmacological prevention and management of heart failure. The Medical Journal of Australia. 217(4). 212–217. 23 indexed citations

Driscoll, Andrea, Helena Romaniuk, Diem Dinh, et al.. (2021). Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure. International Journal of Cardiology. 350. 69–76. 3 indexed citations

Amerena, John, et al.. (2020). Combating Inflammation in Cardiovascular Disease. Heart Lung and Circulation. 30(2). 197–206. 41 indexed citations

dʼEmden, Michael C, John Amerena, Gary Deed, Carol A. Pollock, & Mark E. Cooper. (2017). SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 136. 23–31. 16 indexed citations

10.

Spencer, Ryan & John Amerena. (2015). Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses. American Journal of Cardiovascular Drugs. 15(6). 395–401. 10 indexed citations

11.

O’Neil, Adrienne, C. Barr Taylor, Kristy Sanderson, et al.. (2014). Efficacy and Feasibility of a Tele-health Intervention for Acute Coronary Syndrome Patients with Depression: Results of the “MoodCare” Randomized Controlled Trial. Annals of Behavioral Medicine. 48(2). 163–174. 32 indexed citations

12.

Flaker, Greg, Renato D. Lópes, Elaine M. Hylek, et al.. (2014). Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 64(15). 1541–1550. 81 indexed citations

13.

Amerena, John, et al.. (2012). Pharmacist-led lipid clinic for surgical patients with peripheral vascular disease. Figshare. 93(1107). 83–87. 4 indexed citations

14.

Stewart, Simon, M. Carrington, Craig S. Anderson, et al.. (2012). Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ. 345(nov20 1). e7156–e7156. 87 indexed citations

15.

Joynt, Karen E., John Amerena, David Brieger, et al.. (2009). Impact of acute and chronic risk factors on use of evidence-based treatments in patients in Australia with acute coronary syndromes. Heart. 95(17). 1442–1448. 20 indexed citations

16.

Hung, Joseph, Derek P. Chew, John Amerena, et al.. (2007). Implications of Diabetes in Patients with Acute Coronary Syndromes (ACS). Heart Lung and Circulation. 16. S125–S125. 2 indexed citations

17.

Thompson, Peter L., Ian T. Meredith, John Amerena, et al.. (2004). Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial. American Heart Journal. 148(1). 91–91. 76 indexed citations

18.

Palatini, Paolo, Lisa Krause, John Amerena, et al.. (2001). Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study.. Journal of Hypertension. 19(7). 1217–1222. 15 indexed citations

19.

Yarows, Steven A. & John Amerena. (1999). Determination of accuracies of 10 models of home blood pressure monitors using an oscillometric simulator. Blood Pressure Monitoring. 4(1). 45–52. 10 indexed citations

20.

Rahman, Syed N., William E. Haley, Carla Yunis, et al.. (1998). Impact of Ethnicity on Left Ventricular Mass and Relative Wall Thickness in Essential Hypertension. The American Journal of Cardiology. 81(4). 412–417. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact